Otsuka and Ionis report positive data in Phase III FUSION trial of ulefnersen

​

Otsuka Pharmaceutical Development & Commercialization, Otsuka Pharmaceutical, and Ionis Pharmaceuticals have reported encouraging top-line data from the Phase III FUSION trial.

The post Otsuka and Ionis report positive data in Phase III FUSION trial of ulefnersen appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.